期刊文献+

肿瘤坏死因子样微弱凋亡诱导因子对骨关节炎软骨细胞作用实验研究 被引量:6

Discussion the role of TWEAK on the chondrocytes of Osteoarthritis
下载PDF
导出
摘要 目的研究肿瘤坏死因子样微弱凋亡诱导因子(TWEAK)对体外培养骨关节炎(OA)软骨细胞的作用,同时探讨炎性细胞因子白细胞介素-1β(IL-1β)和肿瘤坏死因子α(TNF-α)与TWEAK之间的关系。方法体外培养OA患者原代软骨细胞,分别用TWEAK(75ng/mL),TWEAK(75ng/mL)和IL-1β(5ng/mL),TWEAK(75ng/mL)和TNF-α(5ng/mL)作用细胞48h,MTT检测细胞因子对软骨细胞的增殖作用影响;ELISA检测细胞培养上清液中MMP-13、IL-6和Fas的分泌表达。结果 MTT结果表明细胞因子刺激软骨细胞后对细胞增殖无明显影响。TWEAK和IL-1β组诱导MMP-13表达增加(P<0.05);TWEAK和IL-1β组,TWEAK和TNF-α组均诱导IL-6表达增加(P<0.05)。3组Fas分泌表达差异无统计学意义(P>0.05)。结论 IL-1β与TWEAK,TNF-α与TWEAK分别诱导OA软骨细胞MMP-13和IL-6表达增加,可能参与关节软骨损伤和OA的病程发展。 Objective To investigate the role of TWEAK on the OA chondrocytes,and to discuss the relationship between IL-1β and TWEAK,TNF-α and TWEAK.Methods Chondrocytes from OA patients were cultured in vitro,stimulated by TWEAK(75 ng/mL),TWEAK(75 ng/mL) with IL-1β(5 ng/mL),TWEAK(75 ng/mL) with TNFα(5 ng/mL) for 48 h.The cells proliferation rate was analyzed by MTT.ELISA was used to detect the concentration of MMP-13,IL-6 and Fas in supernatant.Results The chondrocytes proliferation was not influenced by these cytokines.The expression of MMP-13 could be induced by TWEAK with IL-1β stimulation(P0.05).IL-6 expression induced by TWEAK with IL-1β or TWEAK with TNF-α were higher than the other groups(P0.05).There was no significance change in the expression of Fas.Conclusion TWEAK with IL-1β,TWEAK with TNF-α could induce the OA chondrocytes to synthesize MMP-13 and IL-6,which might affect pathological process of OA.
出处 《检验医学与临床》 CAS 2013年第16期2065-2066,2068,共3页 Laboratory Medicine and Clinic
基金 国家自然科学基金(30972749) 四川省科技厅应用基础项目(2008JY0013)
关键词 骨关节炎 肿瘤坏死因子样微弱凋亡诱导因子 白细胞介素-1Β 肿瘤坏死因子-α osteoarthritis TWEAK interleukin-1β tumor necrosis factor-α
  • 相关文献

参考文献11

  • 1Rubin RJ,Dietrich KA, Hawk AD. Clinical and economic impact of implementing a comprehensive diabetes management program in managed care[J]. J Clin Endocrinol Metab, 1998,83(8) .. 2635-2642.
  • 2Winkles JA. The TWEAK-Fnl4 cytokine-receptor axis: discovery, biology and therapeutic targeting E J]. Nat Rev Drug Discov, 2008,7 ( 5 ) .. 411-425.
  • 3Haas S, Straub RH. Disruption of rhythms of molecular clocks in primary synovial fibroblasts of patients with os- teoarthritis and rheumatoid arthritis, role of IL-113/TNF. [J]. Arthritis Res Ther,2012,14(3) ..122 125.
  • 4夏丽萍,肖卫国,李俊松,丁爽,鲁静.TWEAK诱导类风湿关节炎成纤维样滑膜细胞合成MMP-3的实验研究[J].细胞与分子免疫学杂志,2009,25(1):46-48. 被引量:10
  • 5Perper SJ, Browning B, Burkly LC, et al. TWEAK is a no- vel arthritogenic mediator[J]. J Immunol, 2006,177 (4) : 2610-2620.
  • 6Lim H,Park H, Kim HP. Effects of flavonoids on matrix metalloproteinase-13 expression of interleukin-ll3-treated articular chondrocytes and their cellular mechanisms:inhi- bition of e-Fos/AP-1 and JAK/STAT signaling pathways [J]. J Pharmacol Sci,2011,116(2) :221-231.
  • 7Yamana J, Morand EF, Manabu T, et al. Inhibition of TNFinduced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes[J]. Cell Immunol,2012, 272(2) ..293 298.
  • 8Ikner A, Ashkenazi A. TWEAK induces apoptosis through a death-signaling complex comprising recepto]interacting pro- tein 1 (RIP1), Fas-associated death domain (FADD), and caspase-8[J]. J Biol Chem,2011,286(24) :21546 21554.
  • 9Dharmapatni AA, Smith MD, Crotti TN, et al. TWEAK and Fn14 expression in the pathogenesis of joint inflam marion and bone erosion in rheumatoid arthritis[J]. Ar- thritis Res Ther,2011,13(2) :RS1.
  • 10Saitoh T, Nakayama M, Nakano H, et al. TWEAK in duces NF-kappaB2 pl00 processing and long lasting NF kappaB activation[J]. Biol Chem, 2003,278 (38) : 36005 36012.

二级参考文献9

  • 1Huber LC, Distler O, Tarner I, et al. Synovial fibroblasts; keyplayers in rheumatoid arthritis [ J ]. Rheurnatology ( Oxford), 2006, 45 ( 6 ) : 669 - 675.
  • 2Chicheportiche Y, Chicheportiche R, Sizing I, et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies [J]. Arthritis Res, 2002, 4(2) : 126 -133.
  • 3Kamijo S, Nakajima A, Kamata K, et al. Involvement of TWEAK/ Fn14 interaction in the synovial inflammation of RA[ J]. Rheumatology (Oxford), 2008, 47(4): 442 -450.
  • 4Rannou F, Francois M, Corvol MT, et al. Cartilage breakdown in rheumatoid arthritis[J]. Joint Bone Spine, 2006, 73(1 ): 29-36.
  • 5Kamata K, Kamijo S, Nakajima A, et al. Involvement of TNF-like weak inducer of apoptosis in the pathogenesis of collagen-induced arthritis[J]. J Immunol, 2006, 177(9):6433-6439.
  • 6Perper SJ, Browning B, Burkly LC, et al. TWEAK is a novel arthritogenic mediator [ J ]. J Immunol, 2006, 177 (4) : 2610 - 2620.
  • 7Nanki T. Molecular mechanisms of bone destruction in rheumatoid arthritis[J]. Clin Calcium, 2007, 17(4) : 510 -516.
  • 8Han S, Yoon K, Lee K, et al. TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors [ J ]. Biochem Biophys Res Commun, 2003, 305(4): 789-796.
  • 9Yepes M, Winkles JA. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases[ J]. Drug News Perspect, 2006 , 19(10) : 589 -595.

共引文献9

同被引文献66

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部